Gain-of-Function and Loss-of-Function Mutations in the RyR2-Expressing Gene Are Responsible for the CPVT1-Related

Roshan Paudel1,2, Mohsin Saleet Jafri1,3, Aman Ullah1

  • 1School of Systems Biology, George Mason University, Fairfax, VA 22030, USA.

PubMed

Insights

Mutations in the ryanodine receptor (RyR2) gene can cause cardiac arrhythmia. Computational models suggest gain-of-function and loss-of-function mutations lead to arrhythmias, while SOICR and binding protein destabilization are unlikely mechanisms.

Area of Science:

  • Cardiology
  • Computational Biology
  • Molecular Biology

Background:

  • Mutations in the ryanodine receptor (RyR2) gene are linked to sudden cardiac death (SCD) and catecholaminergic polymorphic ventricular tachycardia (CPVT1).
  • Four proposed mechanisms for RyR2 mutation-induced arrhythmia include gain-of-function (GOF), binding protein destabilization, store-overload-induced Ca2+ release (SOICR), and loss-of-function (LOF).

Purpose of the Study:

  • To computationally investigate the four proposed mechanisms of RyR2 mutation-associated arrhythmia.
  • To analyze how altered Ca2+ dynamics in mutant RyR2 myocytes contribute to arrhythmogenic episodes under adrenergic stimulation or pauses.

Main Methods:

  • Development of a local control stochastic model of a ventricular cardiac myocyte.
  • Incorporation of 20,000 cardiac dyads with stochastically gated L-type Ca2+ channels (LCCs) and RyR2s.
  • Integration of recent experimental findings into model parameters to test proposed mechanisms.

Main Results:

  • The computational model did not support SOICR or binding protein destabilization as arrhythmogenic mechanisms in mutant RyR2 myocytes.
  • Gain-of-function (GOF) mutations were associated with variations in action potential amplitude and duration.
  • Loss-of-function (LOF) mutations were linked to early afterdepolarizations (EADs), precursors to arrhythmia.

Conclusions:

  • Computational modeling supports GOF and LOF mutations as mechanisms leading to arrhythmia.
  • The study casts doubt on the feasibility of SOICR as a primary mechanism for RyR2 mutation-associated arrhythmia.